Shengwei Hu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Shengwei Hu has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
Haihua Yang
College of Life Sciences, Shihezi University, China
1 shared publication- Haihua Yang
College of Life Sciences, Shihezi University, Shihezi 832003, China
1 shared publication Hongfang Li
College of Life Sciences, Shihezi University, China
1 shared publication- Hui Wang
State Key Laboratory of Pathogen and Biosecurity, Academy of Military Medical Sciences, Beijing 100071, China
1 shared publication Jiao Jiao
College of Life Sciences, Shihezi University, China
1 shared publication- Jinlong Bai
College of Life Sciences, Shihezi University, Shihezi 832003, China
1 shared publication
Latest Publications
- Open Access
- 23 April 2026
- Published by MDPI AG in Microorganisms
- Vol. 14 (5) , 953
Prophage-Derived Endolysin E1 Synergizes with Meropenem Against Acinetobacter baumannii
Carbapenem-resistant Acinetobacter baumannii (CRAB) is classified as a critical priority pathogen by the World Health Organization, and new therapeutic alternatives are urgently needed. In this study, we performed genomic mining of 27,531 A. baumannii genomes and identified 5144 prophage-derived endolysin candidates. Four highly prevalent candidates (E1–E4) were recombinantly expressed and functionally evaluated against A. baumannii. Among them, E1 exhibited the strongest bactericidal activity against reference strains ATCC 19606 and CMCC 25001, with a minimum inhibitory concentration in the micromolar range. E1 effectively disrupted preformed biofilms (>60% reduction) and remained stable under a broad range of temperatures (4–60 °C), pH values (6–8), and NaCl concentrations (up to 500 mM). Structural analysis indicated that E1 adopts a canonical lysozyme-like fold with key residues for peptidoglycan binding, and its lytic activity in vitro relied on 1 mM EDTA-mediated outer membrane permeabilization. In a murine peritoneal infection model, combination therapy with E1 and meropenem (each at 1 × MIC) significantly increased the survival rate to 66.7% and reduced bacterial loads in blood and multiple organs. This study demonstrates that prophage-derived endolysin E1 acts synergistically with meropenem against A. baumannii, supporting E1 as a promising candidate for developing combination therapies against CRAB.
- 23 April 2026
- Published by MDPI AG in Microorganisms
- Vol. 14 (5) , 953
Open AccessProphage-Derived Endolysin E1 Synergizes with Meropenem Against Acinetobacter baumannii
Carbapenem-resistant Acinetobacter baumannii (CRAB) is classified as a critical priority pathogen by the World Health Organization, and new therapeutic alternatives are urgently needed. In this study, we performed genomic mining of 27,531 A. baumannii genomes and identified 5144 prophage-derived endolysin candidates. Four highly prevalent candidates (E1–E4) were recombinantly expressed and functionally evaluated against A. baumannii. Among them, E1 exhibited the strongest bactericidal activity against reference strains ATCC 19606 and CMCC 25001, with a minimum inhibitory concentration in the micromolar range. E1 effectively disrupted preformed biofilms (>60% reduction) and remained stable under a broad range of temperatures (4–60 °C), pH values (6–8), and NaCl concentrations (up to 500 mM). Structural analysis indicated that E1 adopts a canonical lysozyme-like fold with key residues for peptidoglycan binding, and its lytic activity in vitro relied on 1 mM EDTA-mediated outer membrane permeabilization. In a murine peritoneal infection model, combination therapy with E1 and meropenem (each at 1 × MIC) significantly increased the survival rate to 66.7% and reduced bacterial loads in blood and multiple organs. This study demonstrates that prophage-derived endolysin E1 acts synergistically with meropenem against A. baumannii, supporting E1 as a promising candidate for developing combination therapies against CRAB.
- 6 March 2026
- Published by Elsevier in International Journal of Food Microbiology
- Vol. 453, 111726
Effective biocontrol of Enterococcus hirae in food products by a novel bacteriophage: Insights from genomic and phenotypic analyses
- 6 March 2026
- Published by Elsevier in International Journal of Food Microbiology
- Vol. 453, 111726
Effective biocontrol of Enterococcus hirae in food products by a novel bacteriophage: Insights from genomic and phenotypic analyses